NEULANDLAB · Neuland Laboratories Limited · Financials
Market Cap
270.43B INR
Shares
12.83M
Volume · Nov 13
70.76K
Avg daily vol (3M)
50.13K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
20.23B
+37%
FY2026
Net Income
3.64B
FY2026
Operating Cash Flow
3.47B
+9.2%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| INR | 23.07B | 20.23B | 14.77B | 15.59B | 11.91B | 9.51B | 9.37B | 7.63B |
| INR | 1.04B | 917.4M | 655.47M | 597M | 527.77M | 490.4M | 396.83M | 312.8M |
| INR | 282.75M | 239.47M | 82.97M | 139.97M | 130.67M | 134.95M | 178.98M | 215.74M |
| INR | 6.09B | 4.89B | 3.46B | 4.01B | 2.16B | 821.63M | 1.05B | 529.23M |
| INR | 1.56B | 1.25B | 862.21M | 1.01B | 522.29M | 183.41M | 247.03M | 367.12M |
| INR | 4.53B | 3.64B | 0 | 0 | 1.64B | 638.22M | 806.31M | 162.11M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 564.52M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.